Radiomics on Gadoxetate Disodium-enhanced MRI: Non-invasively Identifying Glypican 3-Positive Hepatocellular Carcinoma and Postoperative Recurrence
- 10 May 2022
- journal article
- research article
- Published by Elsevier BV in Academic Radiology
- Vol. 30 (1), 49-63
- https://doi.org/10.1016/j.acra.2022.04.006
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- CT and MR Imaging Diagnosis and Staging of Hepatocellular Carcinoma: Part I. Development, Growth, and Spread: Key Pathologic and Imaging AspectsRadiology, 2014
- Wnt signaling and hepatocarcinogenesis: Molecular targets for the development of innovative anticancer drugsJournal of Hepatology, 2013
- Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resectionSurgery, 2013
- Positive glypican-3 expression in early hepatocellular carcinoma predicts recurrence after hepatectomyThe Esophagus, 2013
- Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinomaGut, 2012
- Glypican-3 expression and its relationship with recurrence of HCC after liver transplantationWorld Journal of Gastroenterology, 2012
- Expression of Glypican 3 in Ovarian and Extragonadal Germ Cell TumorsAmerican Journal of Clinical Pathology, 2008
- The oncofetal geneglypican 3is regulated in the postnatal liver by zinc fingers and homeoboxes 2 and in the regenerating liver by alpha-fetoprotein regulator 2Journal of Hepatology, 2007
- Advanced Hepatocellular Carcinoma: CT Perfusion of Liver and Tumor Tissue—Initial Experience1Radiology, 2007
- Toward a better understanding of texture in vascular CT scan simulated imagesIEEE Transactions on Biomedical Engineering, 2001